Company Filing History:
Years Active: 2004-2009
Title: Richard James Dobson: Innovator in Antimicrobial Therapy
Introduction
Richard James Dobson is a notable inventor based in Berkshire, GB, recognized for his contributions to the field of antimicrobial therapy. With a total of five patents to his name, Dobson has made significant strides in the understanding and application of genes and proteins.
Latest Patents
His latest patents focus on the identification and utilization of proteins and genes associated with Group B Streptococcus. One of his patents describes a protein from Group B Streptococcus that serves as an outer surface protein, making it a valuable target for antimicrobial therapy. Another patent outlines a series of genes identified in Group B Streptococcus, which may be linked to the organism's outer surface. These genes, or their functional fragments, hold potential for developing therapeutics, such as vaccines aimed at immunizing patients against microbial infections.
Career Highlights
Throughout his career, Richard Dobson has worked with several companies, including Emergent Product Development UK Limited and Microscience Limited. His work in these organizations has contributed to advancements in medical research and product development.
Collaborations
Some of his notable coworkers include Martin John Glenton Hughes and Joseph David Santangelo, who have collaborated with him on various projects.
Conclusion
Richard James Dobson's innovative work in the field of antimicrobial therapy highlights his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving health outcomes through research and development.